Skip to content

Nuvation Bio NUVB Current Debt

Current Debt at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$2.31B-35.1%
Pfizer logo
PfizerPFE
$3.86B+3.0%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$350M+4.2%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$424K
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.03B+3,224%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:ShortTermBorrowings.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's current debt?
Nuvation Bio (NUVB) reported current debt of $5.79M in Q1 2026.
How has Nuvation Bio's current debt changed year-over-year?
Nuvation Bio's current debt increased by 1.8% year-over-year, from $5.69M to $5.79M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.